Propanc Biopharma annual free cash flow
2011
2014
2015
2016
2019
Propanc Biopharma reported −$2.1M in free cash flow for fiscal 2019, an increase of $2.4M from the previous fiscal year.
View full Propanc Biopharma company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-06-30 | −$2.1M | $2.4M | — | — |
| 2016 | 2016-06-30 | −$4.5M | −$3.1M | — | — |
| 2015 | 2015-06-30 | −$1.4M | −$1.7M | — | — |
| 2014 | 2014-06-30 | $226,442 | $1.6M | — | — |
| 2011 | 2011-06-30 | −$1.4M | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | −$1.1M | −$821,570 | — | — |
| Q2 2026 | 2025-12-31 | −$1.0M | −$317,809 | — | — |
| Q1 2026 | 2025-09-30 | −$1.9M | $364,000 | — | — |
| Q3 2019 | 2019-03-31 | −$738,231 | −$21,309 | — | — |
| Q2 2017 | 2016-12-31 | −$321,030 | $761,483 | — | — |
| Q1 2017 | 2016-09-30 | −$683,598 | −$277,207 | — | — |
| Q4 2016 | 2016-06-30 | −$2.3M | −$1.0M | — | — |
| Q3 2016 | 2016-03-31 | −$716,922 | −$290,459 | — | — |
| Q2 2016 | 2015-12-31 | −$1.1M | −$1.3M | — | — |
| Q1 2016 | 2015-09-30 | −$406,391 | −$506,202 | — | — |
| Q4 2015 | 2015-06-30 | −$1.3M | −$1.2M | — | — |
| Q3 2015 | 2015-03-31 | −$426,463 | −$333,273 | — | — |
| Q2 2015 | 2014-12-31 | $172,185 | — | — | — |
| Q1 2015 | 2014-09-30 | $99,811 | — | — | — |
| Q3 2014 | 2014-03-31 | −$35,847 | — | — | — |
| Q3 2011 | 2011-03-31 | −$93,190 | — | — | — |
Propanc Biopharma's latest reported quarter, Q3 2026, generated −$1.1M in free cash flow, a decrease of $821,570 year over year.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Propanc Biopharma filings at SEC.gov ↗